181 related articles for article (PubMed ID: 29302027)
1. KSHV episomes reveal dynamic chromatin loop formation with domain-specific gene regulation.
Campbell M; Watanabe T; Nakano K; Davis RR; Lyu Y; Tepper CG; Durbin-Johnson B; Fujimuro M; Izumiya Y
Nat Commun; 2018 Jan; 9(1):49. PubMed ID: 29302027
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
6. KSHV Topologically Associating Domains in Latent and Reactivated Viral Chromatin.
Campbell M; Chantarasrivong C; Yanagihashi Y; Inagaki T; Davis RR; Nakano K; Kumar A; Tepper CG; Izumiya Y
J Virol; 2022 Jul; 96(14):e0056522. PubMed ID: 35867573
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
Song MJ; Deng H; Sun R
J Virol; 2003 Sep; 77(17):9451-62. PubMed ID: 12915560
[TBL] [Abstract][Full Text] [Related]
8. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
10. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
[TBL] [Abstract][Full Text] [Related]
11. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator.
Wang Y; Tang Q; Maul GG; Yuan Y
J Virol; 2006 Dec; 80(24):12171-86. PubMed ID: 17020951
[TBL] [Abstract][Full Text] [Related]
13. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.
Nakamura H; Lu M; Gwack Y; Souvlis J; Zeichner SL; Jung JU
J Virol; 2003 Apr; 77(7):4205-20. PubMed ID: 12634378
[TBL] [Abstract][Full Text] [Related]
14. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
[TBL] [Abstract][Full Text] [Related]
15. FUS Negatively Regulates Kaposi's Sarcoma-Associated Herpesvirus Gene Expression.
Dunker W; Song Y; Zhao Y; Karijolich J
Viruses; 2018 Jul; 10(7):. PubMed ID: 29986386
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism.
Ueda K; Ishikawa K; Nishimura K; Sakakibara S; Do E; Yamanishi K
J Virol; 2002 Dec; 76(23):12044-54. PubMed ID: 12414946
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.
Nishimura K; Ueda K; Sakakibara S; Ishikawa K; Chen J; Okuno T; Yamanishi K
J Hum Virol; 2001; 4(6):296-305. PubMed ID: 12082396
[TBL] [Abstract][Full Text] [Related]
18. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
19. Modulation of global SUMOylation by Kaposi's sarcoma-associated herpesvirus and its effects on viral gene expression.
Wang J; Guo Y; Wang X; Zhao R; Wang Y
J Med Virol; 2017 Nov; 89(11):2011-2019. PubMed ID: 28639696
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
